INSP inspiresleep.com Profit After Tax

Corporate emblem and logo of inspiresleep.com (INSP)

Inspire Medical Systems (INSP) minimizes external risks by focusing on the stable US market. Implant production and logistics have been outsourced to reliable partners. Quality control and final assembly remain internal processes, which is reflected in the company's aggregate financial performance on the GURU.Markets terminal chart. The value 0.14 shows the current profit metric, highlighting the business's operational resilience.

Net Income: Inspire Sleep (INSP) for 07/04/2022 - 10/29/2026

Financial and market metric breakdowns for Inspire Medical Systems, Inc. (INSP)

- market value and analyst target forecast:
Stock Price Inspire Medical Systems Inc|INSP - Price Target Chart
- market capitalization data:
Market Valuation Inspire Medical Systems Inc|INSP - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Inspire Medical Systems|INSP - Company Net Assets|Market Capitalization to Book Value Ratio inspiresleep.com|INSP - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital Inspire Medical Systems|INSP - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Inspire Medical|INSP - Company Aggregate Debts|Debt to Book Value Inspire Medical Systems Inc|INSP - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Inspire Medical Systems|Quick Liquidity Indicator inspiresleep.com
- company profitability and valuation multiples indicators:
INSP - Net Profit
Fundamental valuation:INSP, Inspire Medical Systems Inc
Flagship merchandise of Inspire Sleep

A closed apnea therapy ecosystem with high patient retention and dependence on FDA and Medicare regulators determines the financial stability of Inspire Medical Systems (INSP). The trend in the company's net income reflects the final business margins, where a stable peak on the chart may signal a risk of capital stagnation, while upward momentum confirms the scaling efficiency of this high-tech model.

Key competitors

Dexcom CGM (DXCM) - Net Profit|Company Net Income Penumbra, Inc.|novanta.com - Profit After Tax|Net Profit HAE|PRCT - Company Net Income|CONMED Corp. - Net Income|Net Profit Pulse Medical PLSE|INMD: Net Income|picardmedical.com - Profit After Payment of Taxes|SRDX: Net Profit|SENS - Net Financial Result|NPCE (NeuroPace Corp) - Net Profit|Net Income Tactile Systems Technology Inc. (TCMD)|Net Income SNWV (Sanuwave Health Inc)|OM (outsetmedical.com) - Final Profit|Company Net Income Electromed ELMD|LNSR - Net Income|AVITA Medical, Inc - Net Profit|Company Net Income Profound Medical Corp.|BDMD: Net Profit|Company Profit EDAP|APYX (Apyx Medical Corp) - Net Profit|IceCure Medical, Ltd. (ICCM) - Net Financial Result|Net Profit LUNG|Net Income telabio.com TELA|Net Profit CTSO (CytoSorbents Corporation)|Net Profit sensushealthcare.com SRTS|ZYXI - Company Net Income|ECOR: Company Net Income|RBOT (vicarioussurgical.com) - Net Income|Inspira Technologies - Final Profit|ICU (SeaStar Medical Holding) - Net Profit|Company Net Income IRIDEX Corp. IRIX|Company Net Income Intelligent Bio Solutions (INBS)|beyondair.net (XAIR) - Annual Net Income|Profusa, Inc. - Net Income|Net Profit STRATA Skin Sciences Inc. SSKN|GlucoTrack - Net Profit|Net Financial Result NanoVibronix Inc. NAOV|Venus Concept (VERO) - Company Net Income|Profit After Tax NUWE (Nuwellis Inc)|Company Net Income Aethlon|Net Income TransEnterix (ASXC)|Net Profit AVGR|BSGM - Company Net Income|Company Net Income Cutera CUTR|KNW: Company Profit|NARI: Net Income|Nevro Medical - Profit After Payment of Taxes|RSLS: Net Profit|SILK - Net Financial Result